Gary M. Huff
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Gary M. Huff. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BMRA | Award / Grant | 20,000 | — | — | Dec 12, 2025 | |
| LH | CEO, LabCorp Diagnostics | Tax Withholding | 69 | $169.15 | $11,671 | Sep 4, 2018 |
| LH | CEO, LabCorp Diagnostics | Sale | 1,610 | $182.50 | $293,825 | May 30, 2018 |
| LH | CEO, LabCorp Diagnostics | Tax Withholding | 1,376 | $163.84 | $225,444 | Apr 4, 2018 |
| LH | CEO, LabCorp Diagnostics | Option Exercise | 446 | — | — | Feb 7, 2018 |
| LH | CEO, LabCorp Diagnostics | Option Exercise | 153 | — | — | Sep 1, 2017 |